Czechia· CZ-0164957
OMEPRAZOL TEVA PHARMA
A omeprazole product containing omeprazole, registered in Czechia by Teva Pharma B.V., Haarlem. The same ATC class is registered in 19 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Omeprazole is registered in 19 of 19 countries.
Countries holding a registration under ATC A02BC01 (omeprazole), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 11 of them publish a price we can compare per daily dose
Omeprazole · ATC A02BC01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of omeprazole costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.10 in Spain to $1.17 in Switzerland — a ×12 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Omeprazole · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.17
- IT Italy$0.46
- ES Spain$0.10
The record
At a glance
SÚKL (Czech Republic)- Active substance
- OMEPRAZOLE
- Manufacturer
- Teva Pharma B.V., Haarlem
- Country
- Czechia (CZ)
- ATC code
- A02BC01
- ATC class
- Omeprazole
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
802 interactions on record for omeprazole.
Graded by severity as the source publishes them — 25 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Omeprazole · interactions on record
802 records
- 25 severe
- 136 moderate
- 62 minor
- 568 info
Most severe, free to view
- ClopidogrelB01AC04severe
- CilostazolB01AC23severe
- NelfinavirJ05AE04severe
- AtazanavirJ05AE08severe
11 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3694851-47c8-4b43-8101-9a3b0b9b582e GET /v1/drugs/c3694851-47c8-4b43-8101-9a3b0b9b582e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "CPS ETD",
"source": "sukl",
"strength": "10MG",
"pack_size": "21",
"substance": "OMEPRAZOLE",
"cz_kod_sukl": "0164957",
"product_type": "CH",
"substance_codes": "8940",
"registration_state": "R",
"registration_number": "09/005/08-C"
}See everything about omeprazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.